drugset
drugset / Trial / NCT03787069

Intravenous Lignocaine vs Placebo

NCT03787069 ↗

Phase 3 Completed 120 enrolled Indus Hospital and Health Network
RandomizedParallel-groupOpen-labelPrevention

Summary

To assess the mean hemodynamic responses post-intubation in patients given intravenous lignocaine pre-intubation as compared to a placebo pre-intubation in patients undergoing laryngoscopy surgery

Timeline

Start
2017-12-20
Primary completion
2018-07-20
Completion
2018-07-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous

Indications

No indication recorded.